{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:50:37Z","timestamp":1790430637277,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,3]],"date-time":"2014-10-03T00:00:00Z","timestamp":1412294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunogenetics"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00251-014-0808-z","type":"journal-article","created":{"date-parts":[[2014,10,2]],"date-time":"2014-10-02T07:38:54Z","timestamp":1412235534000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["HLA dosage effect in narcolepsy with cataplexy"],"prefix":"10.1007","volume":"67","author":[{"given":"Astrid","family":"van der Heide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"Verduijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert W.","family":"Haasnoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos J. M.","family":"Drabbels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert J.","family":"Lammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans H. J.","family":"Claas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,3]]},"reference":[{"key":"808_CR1","volume-title":"International classification of sleep disorders\u2014third edition (ICSD-3)","author":"American Academy of Sleep Medicine","year":"2014","unstructured":"American Academy of Sleep Medicine (2014) International classification of sleep disorders\u2014third edition (ICSD-3). Darien, Illinois"},{"key":"808_CR2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","volume":"369","author":"Y Dauvilliers","year":"2007","unstructured":"Dauvilliers Y, Arnulf I, Mignot E (2007) Narcolepsy with cataplexy. Lancet 369:499\u2013511","journal-title":"Lancet"},{"key":"808_CR3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/gene.2011.24","volume":"12","author":"P Eerligh","year":"2011","unstructured":"Eerligh P, van Lummel M, Zaldumbide A et al (2011) Functional consequences of HLA-DQ8 homozygosity versus heterozygosity for islet autoimmunity in type 1 diabetes. Genes Immun 12:415\u2013427","journal-title":"Genes Immun"},{"key":"808_CR4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s002510050295","volume":"46","author":"MC Ellis","year":"1997","unstructured":"Ellis MC, Hetisimer AH, Ruddy DA et al (1997) HLA class II haplotype and sequence analysis support a role for DQ in narcolepsy. Immunogenetics 46:410\u2013417","journal-title":"Immunogenetics"},{"key":"808_CR5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/00949658208810607","volume":"16","author":"IJ Good","year":"1982","unstructured":"Good IJ (1982) Standardized tail-area probabilities. J Stat Comp Simul 16:65\u201366","journal-title":"J Stat Comp Simul"},{"key":"808_CR6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1469-1809.1955.tb01285.x","volume":"20","author":"JB Haldane","year":"1956","unstructured":"Haldane JB (1956) The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 20:309\u2013311","journal-title":"Ann Hum Genet"},{"key":"808_CR7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1399-0039.2012.01948.x","volume":"80","author":"F Han","year":"2012","unstructured":"Han F, Lin L, Li J et al (2012) HLA-DQ association and allele competition in Chinese narcolepsy. Tissue Antigens 80:328\u2013335","journal-title":"Tissue Antigens"},{"key":"808_CR8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.humimm.2006.10.006","volume":"68","author":"S-C Hong","year":"2007","unstructured":"Hong S-C, Lin L, Lo B et al (2007) DQB1*0301 and DQB1*0601 modulate narcolepsy susceptibility in Koreans. Hum Immunol 68:59\u201368","journal-title":"Hum Immunol"},{"key":"808_CR9","doi-asserted-by":"crossref","unstructured":"Hor H, Kutalik Z, Dauvilliers Y et al (2010) Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet 1\u20135","DOI":"10.1038\/ng.647"},{"key":"808_CR10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2337\/diab.41.3.378","volume":"41","author":"I Khalil","year":"1992","unstructured":"Khalil I, Deschamps I, Lepage V et al (1992) Dose effect of cis- and trans-encoded HLA-DQ alpha beta heterodimers in IDDM susceptibility. Diabetes 41:378\u2013384","journal-title":"Diabetes"},{"key":"808_CR11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.gene.6364106","volume":"5","author":"BPC Koeleman","year":"2004","unstructured":"Koeleman BPC, Lie BA, Undlien DE et al (2004) Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease. Genes Immun 5:381\u2013388","journal-title":"Genes Immun"},{"key":"808_CR12","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.4049\/jimmunol.150.6.2263","volume":"150","author":"WW Kwok","year":"1993","unstructured":"Kwok WW, Kovats S, Thurtle P, Nepom GT (1993) HLA-DQ allelic polymorphisms constrain patterns of class II heterodimer formation. J Immunol 150:2263\u20132272","journal-title":"J Immunol"},{"key":"808_CR13","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/jsr.12044","volume":"22","author":"G Luca","year":"2013","unstructured":"Luca G, Haba-Rubio J, Dauvilliers Y et al (2013) Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study. J Sleep Res 22:482\u2013495","journal-title":"J Sleep Res"},{"key":"808_CR14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4049\/jimmunol.145.1.136","volume":"145","author":"KE Lundin","year":"1990","unstructured":"Lundin KE, Sollid LM, Qvigstad E et al (1990) T lymphocyte recognition of a celiac disease-associated cis- or trans-encoded HLA-DQ alpha\/beta-heterodimer. J Immunol 145:136\u2013139","journal-title":"J Immunol"},{"key":"808_CR15","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/0140-6736(92)90571-J","volume":"339","author":"K Matsuki","year":"1992","unstructured":"Matsuki K, Grumet FC, Lin X et al (1992) DQ (rather than DR) gene marks susceptibility to narcolepsy. Lancet 339:1052\u20131052","journal-title":"Lancet"},{"key":"808_CR16","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1093\/sleep\/17.suppl_8.S60","volume":"17","author":"E Mignot","year":"1994","unstructured":"Mignot E, Lin X, Arrigoni J et al (1994) DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. Sleep 17:S60\u2013S67","journal-title":"Sleep"},{"key":"808_CR17","first-page":"1012","volume":"20","author":"E Mignot","year":"1997","unstructured":"Mignot E, Hayduk R, Black J et al (1997a) HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 20:1012\u20131020","journal-title":"Sleep"},{"key":"808_CR18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1399-0039.1997.tb02761.x","volume":"49","author":"E Mignot","year":"1997","unstructured":"Mignot E, Kimura A, Lattermann A et al (1997b) Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy. Tissue Antigens 49:329\u2013341","journal-title":"Tissue Antigens"},{"key":"808_CR19","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/318799","volume":"68","author":"E Mignot","year":"2001","unstructured":"Mignot E, Lin L, Rogers W et al (2001) Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 68:686\u2013699","journal-title":"Am J Hum Genet"},{"key":"808_CR20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","volume":"355","author":"S Nishino","year":"2000","unstructured":"Nishino S, Ripley B, Overeem S et al (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355:39\u201340","journal-title":"Lancet"},{"key":"808_CR21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1399-0039.1998.tb02952.x","volume":"51","author":"Z Pelin","year":"1998","unstructured":"Pelin Z, Guilleminault C, Risch N et al (1998) HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. US Modafinil in Narcolepsy Multicenter Study Group. Tissue Antigens 51:96\u2013100","journal-title":"Tissue Antigens"},{"key":"808_CR22","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","volume":"6","author":"C Peyron","year":"2000","unstructured":"Peyron C, Faraco J, Rogers W et al (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6:991\u2013997","journal-title":"Nat Med"},{"key":"808_CR23","first-page":"626","volume":"62","author":"Z \u0160id\u00e0k","year":"1967","unstructured":"\u0160id\u00e0k Z (1967) Rectangular confidence region for the means of multivariate normal distributions. J Am Stat Assoc 62:626\u2013633","journal-title":"J Am Stat Assoc"},{"key":"808_CR24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5665\/sleep.3300","volume":"37","author":"M Tafti","year":"2014","unstructured":"Tafti M, Hor H, Dauvilliers Y et al (2014) DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep 37:19\u201325","journal-title":"Sleep"},{"key":"808_CR25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","volume":"27","author":"TC Thannickal","year":"2000","unstructured":"Thannickal TC, Moore RY, Nienhuis R et al (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:469\u2013474","journal-title":"Neuron"},{"key":"808_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0198-8859(97)00024-4","volume":"53","author":"E Thorsby","year":"1997","unstructured":"Thorsby E (1997) Invited anniversary review: HLA associated diseases. Hum Immunol 53:1\u201311","journal-title":"Hum Immunol"},{"key":"808_CR27","doi-asserted-by":"crossref","first-page":"12390","DOI":"10.1073\/pnas.2135229100","volume":"100","author":"W Vader","year":"2003","unstructured":"Vader W, Stepniak D, Kooy Y et al (2003) The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci U S A 100:12390\u201312395","journal-title":"Proc Natl Acad Sci U S A"},{"key":"808_CR28","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jpain.2012.05.003","volume":"13","author":"DE Rooijen van","year":"2012","unstructured":"van Rooijen DE, Roelen DL, Verduijn W et al (2012) Genetic HLA associations in complex regional pain syndrome with and without dystonia. J Pain 13:784\u2013789","journal-title":"J Pain"},{"key":"808_CR29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0198-8859(93)90143-O","volume":"37","author":"W Verduyn","year":"1993","unstructured":"Verduyn W, Doxiadis II, Anholts J et al (1993) Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant. Hum Immunol 37:59\u201367","journal-title":"Hum Immunol"},{"key":"808_CR30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1469-1809.1955.tb01348.x","volume":"19","author":"B Woolf","year":"1955","unstructured":"Woolf B (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19:251\u2013253","journal-title":"Ann Hum Genet"}],"container-title":["Immunogenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-014-0808-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00251-014-0808-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-014-0808-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:01:39Z","timestamp":1689552099000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00251-014-0808-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["808"],"URL":"https:\/\/doi.org\/10.1007\/s00251-014-0808-z","relation":{},"ISSN":["0093-7711","1432-1211"],"issn-type":[{"value":"0093-7711","type":"print"},{"value":"1432-1211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,3]]}}}